Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Upadacitinib may effectively treat alopecia areata without side effects.

Androgens increase growth factors in skin cells, which may lead to acne.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Alopecia areata patients may have higher blood pressure and blood sugar, indicating a future risk of metabolic issues.

Alopecia areata is linked to thyroid diseases, and thyroid testing may help affected patients.

Low free thyroxine (FT4) is common in young lupus patients and needs quick diagnosis and treatment.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Skin cells produce and activate vitamin D, which regulates skin functions and supports hair growth.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Injected human hair follicle cells can create new, small hair follicles in skin cultures.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

A special hydrogel helps heal skin without scars and regrows hair.